ReviewMolecular oncology2026
European Code Against Cancer, 5th edition - tobacco and nicotine containing products, second-hand smoke, alcohol and cancer.
Review in Molecular oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Optimising the European Code Against Cancer, 5th edition, to increase awareness of avoidable cancer risks in all socioeconomic groups.Molecular oncology · 2026Trial
- Global trends and projections of tracheal, bronchial, and lung cancer (TBL) associated with secondhand smoke (SHS) exposure in women: insights of the Global Burden of Disease (GBD) study 2021 from 1990 to 2021 and prediction to 2035.Journal of thoracic disease · 2026Article
- European Code Against Cancer 5th edition: 14 ways you can help prevent cancer.The Lancet regional health. Europe · 2026Review
- European Code Against Cancer, 5th edition - a tool for enhancing cancer prevention.Molecular oncology · 2026Article
- European Code Against Cancer, 5th edition - outdoor and indoor air pollution and cancer.Molecular oncology · 2026Review
- European Code Against Cancer, 5th edition - diet, excess body weight, physical activity, sedentary behavior, breastfeeding, and cancer.Molecular oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
Tobacco use, second-hand tobacco smoke (SHS) exposure and alcohol consumption are well-established carcinogens and major public health concerns. In the European Union (EU), tobacco and alcohol use are the leading preventable causes of cancer and four other major noncommunicable diseases (NCDs), significantly contributing to NCD-related morbidity and mortality. Despite declining prevalence, consumption of these substances is still high in the region, especially among the most deprived. There is strong evidence that quitting smoking, minimising exposure to SHS and eliminating or reducing alcohol intake substantially lowers the risk of cancer. Comprehensive public health strategies at both the individual and population level are crucial to prevent cancer and other NCDs. Scientific evidence leads to two recommendations for individual action on tobacco in the European Code Against Cancer, 5th edition: (1) 'Do not smoke. Do not use any form of tobacco, or vaping products. If you smoke, you should quit'; and (2) 'Keep your home and car free of tobacco smoke'; and one on alcohol: (3) 'Avoid alcoholic drinks'.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.